I am an Assistant Professor of Medicine at the University of Pennsylvania Perelman School of Medicine, a practicing interventional pulmonologist, and a physician-scientist. Clinically trained in internal medicine, pulmonary diseases, critical care medicine, and interventional pulmonology, I see patients at the Harron Lung Center Perelman and perform advanced diagnostic and therapeutic bronchoscopy and minimally invasive thoracic procedures at the Hospital of the University of Pennsylvania.
My National Cancer Institute (NCI)-funded research program focuses on the early detection of lung cancer and the optimization of the thoracic oncology diagnostic process. I am the Principal Investigator of the first investigator-initiated pragmatic randomized clinical trial assessing the effect of a pulmonary nodule risk stratification biomarker on medical decision-making (NCT05968898) and a member of the Population-based Research to Optimize the Screening Process (PROSPR) Lung Consortium, a NCI-funded multi-institutional research collaboration.
I received my undergraduate degree from Yale College and MD from the Yale University School of Medicine. I completed internal medicine residency at Yale-New Haven Hospital and pulmonary, critical care, and interventional pulmonology fellowships at the Hospital of the University of Pennsylvania. I also earned a Master of Science in Clinical Epidemiology (MSCE) degree from the University of Pennsylvania.
Publications
Kim RY, Gupta A, Ang L, Rendle KA Contemporary Pulmonary Nodule Evaluation and Management in the U.S.: A Mixed Methods Study , CHEST: 2026,S0012-3692(26)06306-3
Kim RY, Rings A, Pickup LC, Ibrahim O, Vachani A Theoretical Clinical Utility of Advanced Practice Provider Use of an Artificial Intelligence Radiomics-based Tool for Pulmonary Nodule Evaluation and Management , CHEST Pulmonary, 4(2): 2026,100242
Ezenwankwo E, Nnate D, Kim RY, Eberth JM, Kim YW Reframing Computed Tomography-Associated Cancer Concerns in Lifesaving Screening: Keeping the Focus on Lives Saved , The Lancet Regional Health – Americas, 58: 2026,101451
Burnett-Hartman AN, Carroll NM, Wain KF, Hixon BP, Vachani A, Greenlee RT, Honda SA, Kim RY, Neslund-Dudas C, Oshiro CES, Rendle KA, Simoff M, Ritzwoller DP Lung Cancer Yield by Baseline Screening Lung-RADS Assignment and Patient Factors: The PROSPR-Lung Consortium , CHEST Pulmonary, 4(2): 2026,100243
Caruso CR, Kim RY Improving Lung Cancer Screening Diagnostic Efficiency , Current Opinion in Pulmonary Medicine , 32(4): 2026,261-269
Kim RY, Gupta A, Ang L, Bilger A, Vachani A, Rendle KA Clinicians’ Cancer Risk Assessment among Patients with Pulmonary Nodules: A Qualitative Study , Ann Am Thorac Soc, 23(3): 2026,458-463
Ritzwoller DP, Carroll NM, Wain KF, Hixon BP, Kim RY, Maiyani M, Steiner JS Examining Trends in Lung Cancer Screening over 10 Years: Eligibility, Participation, Cancer Detection, and Quality Implications , Cancer, 131(24): 2025,e70211
Caruso CR, Vachani A, Kim RY Monitoring the Harms of Lung Cancer Screening: Why the Non-Malignant Resection Rate Is Our Best Bet , Journal of the American College of Radiology, 22(12): 2025,1569-1571
Caruso CR, Kim RY, Rendle KA, Vachani A Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification , CHEST, 168(5): 2025,1271-1274
Kim RY The Association of Lung Cancer Screening Centralization With Annual Adherence Rates , CHEST, 168(3): 2025,572-573
